A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids

A patient with antisynthetase syndrome with pulmonary and muscular involvement was treated with immunosuppressive agents without corticosteroids. Rituximab was added to mycophenolate mofetil therapy with improvement in lung functional and imaging findings and normalization of creatine kinase levels....

Descripción completa

Detalles Bibliográficos
Autores principales: Sieradzka, Agnieszka Ewa, Naccini, Bruno, Fontana, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426970/
https://www.ncbi.nlm.nih.gov/pubmed/36051166
http://dx.doi.org/10.12890/2022_003324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426970/
https://www.ncbi.nlm.nih.gov/pubmed/36051166
http://dx.doi.org/10.12890/2022_003324

Ejemplares similares